Clinical Trials Logo

Clinical Trial Summary

The main objective of this study is to characterize the evolution (over a period of 28 days) of superficial and deep bacterial skin flora in patients with stage 3 or 4 sacral pressure ulcers (bedsores). Changes in terms of pathogenic, potentially pathogenic and non-pathogenic bacterial species at the intra-individual and population levels.


Clinical Trial Description

The secondary objectives of this study are:

A. To compare bacterial communities collected from superficial versus deep samples of stage 3 or 4 sacral bedsores using metagenomics and standard culturing methods.

B. To characterize the evolution of digestive bacterial flora in the same patients over a period of 28 days. Changes in terms of pathogenic, potentially pathogenic and non-pathogenic will be described, as well as the appearance of resistance phenotypes.

C. To characterize the evolution of urinary bacterial flora in the same patients over a period of 28 days. Changes in terms of pathogenic, potentially pathogenic and non-pathogenic will be described, as well as the appearance of resistance phenotypes. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02055729
Study type Observational
Source Centre Hospitalier Universitaire de Nimes
Contact
Status Completed
Phase
Start date May 11, 2015
Completion date September 21, 2017

See also
  Status Clinical Trial Phase
Terminated NCT02412046 - Quantification of the Pressure Threshold Related to Tissue Injury in Bedriden Paraplegics N/A
Terminated NCT03114345 - Correlation Between Pressure Differences and Micro-vascularization Changes in Bedridden Paraplegic Patient N/A